 VANCOUVER, Washington, June 01, 2021 GLOBE NEWSWIRE -- CytoDyn Inc. OTC.QB: CYDY, CytoDyn or the Company, a late-stage biotechnology company developing VyrologixTM leronlimab, a CCR5 antagonist with potential multiple therapeutic indications, announced today a joint collaborative effort with Philippine Airlines as the preferred partner in transporting leronlimab to the Philippines for treatment of critically ill COVID-19 patients. 